Contemporary Issues in Pharmaceutical Patent Law: Setting the Framework and Exploring Policy Options

Contemporary Issues in Pharmaceutical Patent Law

Setting the Framework and Exploring Policy Options
 
Edition number: 1
Publisher: Routledge
Date of Publication:
 
Normal price:

Publisher's listprice:
GBP 145.00
Estimated price in HUF:
70 035 HUF (66 700 HUF + 5% VAT)
Why estimated?
 
Your price:

63 032 (60 030 HUF + 5% VAT )
discount is: 10% (approx 7 004 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:

Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
  Piece(s)

 
 
 
 
Product details:

ISBN13:9781138934481
ISBN10:1138934488
Binding:Hardback
No. of pages:258 pages
Size:234x156 mm
Weight:640 g
Language:English
Illustrations: 5 Illustrations, black & white; 5 Tables, black & white
0
Category:
Short description:

This collection explores the complexities associated with the intersection of pharmaceutical law and policy and public health. Focusing on patent and relevant regulatory laws, the collection provides a comprehensive overview of the most important and pressing issues governments are currently facing in regards to ensuring access to medicines at an affordable cost. Each chapter focuses on a separate issue and offers clear, balanced and detailed analysis of the international framework, trends and available policy options.

Long description:

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges



'The editors have mustered a wide range of authors, including legal practitioners, academics and a Constitutional Court Justice, to opine on a broad range of topical issues confronting rule-makers concerning pharmaceutical patent law. This diversity makes for a varied discussion.' 


John A. Tessensohn, European Intellectual Property Review



 'A solid reference book for scholars and those interested in governments? struggle between incentivising innovation and access to affordable medicine.'


John A. Tessensohn, European Intellectual Property Review



 

Table of Contents:

1. Introduction: A Holistic Approach to Pharmaceutical Patent Law and Policy, Bryan Mercurio and Daria Kim  Part 1: Pharmaceutical Patents and Related Types of Protection  2. Patentability of Pharmaceutical Inventions under TRIPS: Domestic Court Practice Testing International Policy Space, Roberto Romandini and Henning Grosse Ruse-Khan  3. Biologics, Biosimilars and Other Idiosyncrasies, Yaniv Heled  4. Index of Data Exclusivity and Access (IDEAS): An Analysis of Test Data Exclusivity Provisions in Free Trade Agreements and National Laws, Owais Hassan Shaikh  5. Patent Linkage Regulations: The Importance of Context and of Balancing Competing Interests, Bryan Mercurio  Part 2: Balancing Patent Protection with Available Flexibilities  6. The Bolar Exception: Legislative Models and Drafting Options, Carlos Correa  7. Compulsory Licensing: Threats, Use and Recent Trends, Chang-fa Lo  8. A Manufacturing for Export Exception, Xavier Seuba, Luis Mariano Genovesi and Pedro Roffe  Part 3: A Broader View on Incentives for Pharmaceutical Innovation  9. The Price of Exclusivity: The Economics of Patent Extensions and Data Protection, Aidan Hollis and Paul Grootendorst  10. Rationalizing Innovation Incentives under Drug Approval Regulation: National Policy Perspective, Daria Kim  11. The Trans-Pacific Partnership Agreement and Its Implications for Access to Medicine, Jakkrit Kuanpoth